Colorado State University is planning to open a new research center dedicated to studying cannabinoids this spring, thanks to a $1.5 million donation.

The new facility, located in the College of Natural Sciences on the Fort Collins campus, will enable students and faculty to study the formulation of cannabinoids, separation efficiencies, efficacy testing and more, according to announcement Thursday. The money will be used fund research, cover operating expenses and purchase equipment.

“Cannabinoids have already been proven effective in a number of clinical applications, and there are more than 100 other compounds that have been identified in hemp that could have an impact in other areas,” said Melissa Reynolds, professor of chemistry and associate dean for research in the College of Natural Sciences, in a statement. “Honestly, the possibilities are limitless – we can explore all types of research that were never available before.”

Research will be done in partnership with Golden-based Panacea Life Sciences, which made the donation. The company, founded by CSU alumna Leslie Buttorff, manufactures cannabidiol (CBD) products for human and pets.

“CSU offers expertise in the complete cannabinoid value chain, including botany, chemistry, biology, psychology, agricultural sciences, statistics and veterinary research,” Buttorff said. “Panacea’s focus in developing scientifically driven and medically focused products will be further advanced with our partnership with CSU.”

CSU is currently renovating part of its chemistry building to accommodate the new cannabinoid center. Both undergraduate and graduate students will be involved in research, the university said.